Related Experiment Video
Updated: Jul 1, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Treatment planning for a synchrotron-based radiotherapy modality
S Manolopoulos1, C Wojnecki, S Green
1Department of Medical Physics, University Hospital Birmingham NHS Trust, Birmingham B15 2TH, UK. s.manolopoulos@bham.ac.uk
Abstract:
Contrast enhanced radiotherapy (CERT) achieves biologically localised dose enhancement through the preferential uptake of high-Z media by the tumour cells. A treatment planning software originally developed for boron neutron capture therapy (BNCT) has been developed to evaluate treatment plans for CERT. A realistic test case of a brain tumour based on actual CT scans was used to calculate dose distributions with and without the presence of an iodinated contrast medium. An enhancement of dose was observed at all depths with the introduction of iodine and the corresponding dose enhancement factors were calculated for various concentrations.

